Key considerations for physicians when faced with a pregnant patient with MPN

Gaby Hobbs, MD, Massachusetts General Hospital, Boston, MA, underlines key considerations for physicians when faced with a pregnant patient with myeloproliferative neoplasms (MPN). Dr Hobbs suggests changes to cytoreduction and the introduction of aspirin and low molecular weight heparin during different stages of pregnancy and highlights the importance of collaborating with an obstetrician to monitor patients. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.